United Pharm (033270) — Net Asset Quality Index
United Pharm (033270) has a Net Asset Quality Index of 81.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩563.13 Billion minus total liabilities of ₩103.96 Billion yields net assets of ₩459.17 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 033270 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
United Pharm Net Asset Quality Index Over Time (2011–2025)
This chart shows how United Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2025. As of March 2026, the index stands at 81.5%, representing net assets of ₩459.17 Billion against total assets of ₩563.13 Billion KRW. Explore cash flow conversion of United Pharm to assess how effectively this company generates cash.
Annual Net Asset Quality Index for United Pharm (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for United Pharm from 2011 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of United Pharm.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.5% | ₩454.63 Billion | ₩519.49 Billion | ₩64.86 Billion | ▲ +1.8 pp |
| 2024 | 85.7% | ₩406.21 Billion | ₩473.93 Billion | ₩67.72 Billion | ▲ +4.9 pp |
| 2023 | 80.8% | ₩378.68 Billion | ₩468.86 Billion | ₩90.18 Billion | ▼ -0.1 pp |
| 2022 | 80.8% | ₩337.86 Billion | ₩417.89 Billion | ₩80.03 Billion | ▲ +1.7 pp |
| 2021 | 79.1% | ₩300.71 Billion | ₩380.03 Billion | ₩79.32 Billion | ▲ +0.8 pp |
| 2020 | 78.3% | ₩276.89 Billion | ₩353.43 Billion | ₩76.54 Billion | ▲ +1.3 pp |
| 2019 | 77.0% | ₩255.10 Billion | ₩331.24 Billion | ₩76.14 Billion | ▲ +1.3 pp |
| 2018 | 75.7% | ₩228.48 Billion | ₩301.95 Billion | ₩73.47 Billion | ▼ -0.2 pp |
| 2017 | 75.9% | ₩201.68 Billion | ₩265.80 Billion | ₩64.11 Billion | ▲ +0.1 pp |
| 2016 | 75.7% | ₩177.39 Billion | ₩234.22 Billion | ₩56.83 Billion | ▲ +1.2 pp |
| 2014 | 74.5% | ₩161.83 Billion | ₩217.10 Billion | ₩55.27 Billion | ▲ +1.5 pp |
| 2013 | 73.1% | ₩141.44 Billion | ₩193.54 Billion | ₩52.10 Billion | ▲ +1.9 pp |
| 2012 | 71.2% | ₩133.48 Billion | ₩187.58 Billion | ₩54.10 Billion | ▲ +4.7 pp |
| 2011 | 66.5% | ₩113.04 Billion | ₩170.09 Billion | ₩57.04 Billion | — |